Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleConfirmation, Development

Zic4-Lineage Cells Increase Their Contribution to Visual Thalamic Nuclei during Murine Embryogenesis If They Are Homozygous or Heterozygous for Loss of Pax6 Function

Ziwen Li, Thomas Pratt and David J. Price
eNeuro 9 October 2018, 5 (5) ENEURO.0367-18.2018; DOI: https://doi.org/10.1523/ENEURO.0367-18.2018
Ziwen Li
1Simons Initiative for the Developing Brain, Biomedical Sciences, The University of Edinburgh, Edinburgh EH8 9XD, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ziwen Li
Thomas Pratt
1Simons Initiative for the Developing Brain, Biomedical Sciences, The University of Edinburgh, Edinburgh EH8 9XD, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Pratt
David J. Price
1Simons Initiative for the Developing Brain, Biomedical Sciences, The University of Edinburgh, Edinburgh EH8 9XD, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Our aim was to study the mechanisms that contribute to the development of discrete thalamic nuclei during mouse embryogenesis (both sexes included). We characterized the expression of the transcription factor coding gene Zic4 and the distribution of cells that expressed Zic4 in their lineage. We used genetic fate mapping to show that Zic4-lineage cells mainly contribute to a subset of thalamic nuclei, in particular the lateral geniculate nuclei (LGNs), which are crucial components of the visual pathway. We observed that almost all Zic4-lineage diencephalic progenitors express the transcription factor Pax6 at variable location-dependent levels. We used conditional mutagenesis to delete either one or both copies of Pax6 from Zic4-lineage cells. We found that Zic4-lineage cells carrying either homozygous or heterozygous loss of Pax6 contributed in abnormally high numbers to one or both of the main lateral geniculate nuclei (LGNs). This could not be attributed to a change in cell production and was likely due to altered sorting of thalamic cells. Our results indicate that positional information encoded by the levels of Pax6 in diencephalic progenitors is an important determinant of the eventual locations of their daughter cells.

  • lateral geniculate nucleus
  • Pax6
  • prethalamus
  • thalamus
  • Zic4

Significance Statement

The development of the thalamus is a process in which cells that initially appear similar give rise to distinct cell groups called nuclei. How these nuclei form is poorly understood. We utilized a mouse model in which cells that express the gene Zic4 can be followed. We studied the consequences of knocking out either one or both copies of the gene encoding the Pax6 transcription factor in these Zic4-lineage cells. We found that these mutations had significant effects on the contribution of Zic4-lineage cells to specifically visual thalamic nuclei. This was not attributable to a change in Zic4-lineage cell production in mutants. Rather, we suggest that mutation of Pax6 affects the distribution of Zic4-lineage neurons to specific thalamic nuclei.

Introduction

The diencephalon is one of the two major components of the vertebrate forebrain. It contains several structures essential for brain function, including the thalamus and prethalamus. The thalamus is an important regulator of fundamental processes including sleep, alertness, consciousness and cognition, and is involved in the regulation of corticocortical communication and the relaying of sensory information to the cerebral cortex (Sherman and Guillery, 2002, 2006, 2011; Jones 2007). The thalamus is commonly subdivided into >40 distinct nuclei, distinguished according to their function, cytoarchitecture, anatomic connectivity and gene expression patterns (Jones, 2007; Lim and Golden, 2007; Martinez-Ferre and Martinez, 2012). For example, the lateral geniculate nucleus (LGN) is essential for the processing of visual information. The LGN is divided into two major components: the dorsal LGN (dLGN) relays visual signals from the retina to the visual cortex; the ventral LGN (vLGN) is involved in processing and integration, having inputs from retina, cortex, and superior colliculus and connections to other thalamic nuclei.

Thalamic nuclei develop in the mouse embryo during the final third of gestation as neurons generated from progenitors lining the third ventricle migrate radially into the thalamic mantle zone (Nakagawa and Shimogori, 2012). This process is likely to be regulated by the transcription factor Pax6, which is expressed by most diencephalic progenitors. The relatively few exceptions are located at the zona limitans intrathalamica (ZLI) between the thalamus and prethalamus (Macdonald et al., 1995; Ericson et al., 1997; Robertshaw et al., 2013; Caballero et al., 2014). The expression level of Pax6 varies systematically across the thalamus from high (caudally) to low (rostrally) and is high in the prethalamus. It can, therefore, confer positional identity on diencephalic progenitors, which might contribute to the ability of their daughter neurons to coalesce into discrete nuclei later in development.

Zic4 is a zinc finger transcription factor expressed in embryonic mouse nervous system, including the diencephalon, from embryonic day (E)9.5 on (Aruga et al., 1996a,b; Gaston-Massuet et al., 2005). A previous study reported that it is highly expressed in the postnatal LGN (Horng et al., 2009). We began our study by testing whether cells related by the expression of Zic4 at some time in their lineage (referred to as Zic4-lineage cells) contribute selectively to specific thalamic nuclei. We conducted a detailed analysis of the development of both Zic4 expression and the distributions of Zic4-lineage cells in the embryonic diencephalon and found that Zic4-lineage cells are distributed preferentially to a select subset of thalamic nuclei, in particular the vLGN, by the time of birth. We then studied the consequences of Zic4Cre induced deletions of either one or both copies of Pax6.

Materials and Methods

Mice

All experiments were conducted in accordance with Home Office United Kingdom regulations and University of Edinburgh animal welfare guidelines.

Conditional Pax6 knock-out mice were generated by crossing floxed Pax6 mutant mice Pax6fl/fl (Simpson et al., 2009) with Zic4Cre mice (Rubin et al., 2010), a kind gift from Dr. Thomas Theil at Center for Discovery Brain Sciences at the University of Edinburgh. These mice were crossed with RCE:loxP mice (Miyoshi et al., 2010) to report the Cre activity with the expression of an enhanced green fluorescent protein (EGFP; subsequently referred to as GFP). The triple transgenic mice were maintained on a C57BL/6 background. To obtain Zic4Cre+/−;Pax6fl/fl;RCE+/−, Zic4Cre+/−;Pax6fl/+;RCE+/−, and Zic4Cre+/−;Pax6+/+;RCE+/− embryos (subsequently referred to as Pax6fl/fl, Pax6fl/+, and Pax6+/+), Pax6fl/+;RCE+/− females were crossed with Pax6fl/+;Zic4Cre+/− males. To obtain Zic4Cre+/−;RCE+/− embryos, RCE+/− females were crossed with Zic4Cre+/− males.

Genotyping

Zic4Cre+/− mice were genotyped using primers (forward: GAGGGACTACCTCCTGTACC, reverse: TGCCCAGAGTCATCCTTGGC) to the iCre cassette (Rubin et al., 2010), resulting in a 630-bp PCR product in the mutant. RCE+/− mice were genotyped using three primers (Rosa1: CCCAAAGTCGCTCTGAGTTGTTATC; Rosa2: GAAGGAGCGGGAGAAATGGATATG; and Cag3: CCAGGCGGGCCATTTACCGTAAG) to the EGFP reporter (Miyoshi et al., 2010), resulting in a 550-bp PCR product in the wild type and a 350-bp PCR product in the mutant. Mice carrying the Pax6fl transgene (Simpson et al., 2009) were genotyped using two primers (FP6GtF: AAATGGGGGTGAAGTGTGAG; FP6GtR: TGCATGTTGCCTGAAAGAAG), resulting a 156-bp PCR product in the wild type and a 195-bp PCR product in the mutant.

All Zic4Cre+/−;RCE+/− embryos and pups were distinguished from wild-type mice based on the detection of the GFP reporter using a GFP stereoscope and genotyped for the Pax6fl transgene using the primers described above.

Tissue preparation and histology

The day that the vaginal plug was found was considered as E0.5. For postnatal studies, the birth date was considered as postnatal day (P)0. Embryos were extracted from pregnant females by caesarean section following an overdose of isoflurane and were harvested into ice-cold PBS. For embryos aged from E11.5 to E14.5, whole heads were removed and fixed in 4% (w/v) paraformaldehyde (PFA) in PBS overnight at 4°C. For embryos aged from E15.5 to E18.5, brains were dissected from skulls before proceeding to fixation. P0 pups were anaesthetized by an overdose of sodium pentobarbitone and perfused with 4% PFA through the left ventricle of the heart. The brains were extracted and immersed in 4% PFA for 48 h at 4°C.

Fixed samples were either dehydrated in 70% EtOH and embedded in paraffin for microtome sectioning or cryo-protected in 30% sucrose (w/v) in PBS, embedded in a 1:1 mixture of 30% sucrose (w/v) in PBS and optimal cutting temperature (OCT) compound (Tissue-Tek, Sakura Finetek Europe), and frozen on dry ice for cryostat sectioning. All samples were sectioned coronally at 10 μm.

Fluorescent in situ hybridization

The digoxigenin (DIG)-labeled Zic4 antisense RNA probe was used at a concentration of 1:2000. Fluorescent in situ hybridizations were performed according to a published protocol (Rubin et al., 2010). The plasmid used to generate the Zic4 probe was the IMAGE clone 6400880 (linearised with EcoRI and transcribed with T3 RNA polymerase), a kind gift from Professor Nicoletta Kessaris, Wolfson Institute for Biomedical Research, University College London, United Kingdom.

Immunohistochemistry

Fluorescent immunohistochemistry was performed on paraffin embedded sections according to previously published protocols (Martynoga et al., 2005). Diaminobenzidine (DAB) immunohistochemistry for Pax6 was performed using the Vectastain ABC kit (Vector Laboratories) following an incubation of slides in biotinylated secondary antibodies and slides were incubated in 3% hydrogen peroxide/90% methanol for 30 min to inactivate endogenous peroxidase activities during the rehydration process.

Primary antibodies used were as follow: mouse anti-BrdU IgG1 (1:150, BD Biosciences, RRID:AB_10015219), rabbit anti-Ki67 IgG (1:500, Abcam, RRID:AB_2049848), rabbit anti-pHH3 (Ser10; 1:100, Millipore), mouse anti-Tuj1 IgG (1:400, Abcam), goat anti-GFP IgG (1:150, Abcam), mouse anti-COUP-TFI IgG2A (1:500, R&D Systems, RRID:AB_1964211), mouse anti-COUP-TFII IgG2A (1:1000, R&D Systems, RRID:AB_1964214), mouse anti-LIM1/2 [1:50, Developmental Studies Hybridoma Bank (DSHB), University of Iowa], mouse anti-Nkx2.2 (1:200, DSHB), and mouse anti-Pax6 (AD2.38; a kind gift from Professor Veronica Van Heyningen at Institute of Genetics and Molecular Medicine, University of Edinburgh).

Secondary antibodies used were donkey anti-goat Alexa Fluor 488 (1:200, Invitrogen), rabbit anti-mouse biotin (1:200, Vector Laboratories), goat anti-rabbit biotin (1:200, Vector Laboratories), streptavidin Alexa Fluor 594 (1:200, Invitrogen), donkey anti-mouse Alexa Fluor 568 (1:200, Invitrogen), donkey anti-mouse Alexa Fluor 647 (1:200, Invitrogen), and donkey anti-rabbit Alexa Fluor 647 (1:200, Invitrogen).

Bromodeoxyuridine (BrdU) labeling

A single dose of BrdU (70 μg/g mouse weight, diluted in saline 10 μg/μl) was administrated via intraperitoneal injection to pregnant dams carrying E10.5, E11.5, E12.5, and E13.5 embryos. For birthdate studies, brain tissue was collected from four P0 Zic4Cre+/–;RCE+/–;Pax6+/+ pups for each injection age (E10.5–E13.5). For cell proliferation studies, four embryos were collected for brain tissue 1.5 h after injection for each injection age (E11.5–E12.5).

Imaging, image processing, and cell counting

DAB images were taken with a Leica DFC480 camera connected to a Leica DMNB epifluorescence microscope. Fluorescence images were taken with a Leica DM5500B automated upright microscope connected to a DFC360FX camera and a Nikon A1R confocal microscope.

For birthdating studies, vLGN, dLGN, and ventral posterior (VP) nuclei were outlined and processed in CellProfiler (Lamprecht et al., 2007) using a custom pipeline. RGB images were split into three single-channel gray scale images and a global thresholding was performed to reduce background noises. Cell nuclei were identified using DAPI staining and a cutoff intensity value of 5 was used to distinguish nuclei with positive or negative staining for both BrdU and GFP. All cell nuclei were classified and automatically counted into four categories: GFP-BrdU-, GFP-BrdU+, GFP+BrdU+, and GFP+BrdU-, and proportions of each category were calculated and exported into spreadsheets.

For cell proliferation studies, a box with a fixed width was positioned and stretched to include the whole diencephalic wall for three structures of interest: the prethalamus and the pTH-R and pTH-C in the thalamus. Cropped images were processed in CellProfiler. Cell nuclei segmentation and fluorescence intensity measurements for BrdU, pHH3, Ki67, Tuj1, and GFP were performed as described above, with the same intensity cutoff applied ahead of cell counting.

For cell contribution studies, volumes of vLGN, dLGN, and VP were estimated using the ImageJ Volumest plugin (Merzin, 2008) using a series of 10 coronal sections with a regular interval of 60 μm. Within each section, nuclei were outlined and overlaid with a counting grid. 30% of counting tiles (30 × 30 μm) were randomly sampled using a custom ImageJ plugin (inspired by Wayne Rasband’s ImageJ plugin Grid) and manually counted to calculate densities of all cells and GFP+ cells. The number of all cells in each nucleus was calculated by multiplying its volume and cell density.

Code accessibility

Custom CellProfiler pipeline and ImageJ sampling tile generator plugin will be provided on request.

Statistical analyses

Statistical analyses were conducted using the Prism 7 statistical software (version 7.01, GraphPad Software Inc.). Univariate statistics (mean ± SEM) were performed for all studied variables. One-way ANOVA was performed to study the effect of genotype, and two-way ANOVA was performed to examine the effects of genotype and anterior-posterior position. The Tukey’s post hoc test was performed for all pair-wise comparisons subsequent to the ANOVAs.

Results

Zic4 and Zic4Cre expression in the embryonic diencephalon

We began by thoroughly analyzing and comparing the expression of Zic4 transcripts and GFP reporter in the Zic4Cre+/–;RCE+/– diencephalon at embryonic stages from E11.5 to birth (Figs. 1–3). Whereas in situ hybridizations for Zic4 mRNA revealed the expression patterns of the gene at the time of analysis, GFP revealed cells that were either expressing or at some time in their past expressed Zic4 (Zic4-lineage cells).

In the E11.5 diencephalon (Fig. 1A–F), Zic4 transcripts were detected at highest levels in cells of the prethalamus (Fig. 1C1,D1) and the eminentia thalami (Fig. 1B1). In the prethalamus, the Zic4 transcripts were concentrated in cells on the outer, pial side of the neuroepithelium (Fig. 1E). GFP expression overlapped that of Zic4 transcripts, with GFP+ cells most frequent in the prethalamus and the eminentia thalami (Fig. 1B2,C2,D2). GFP reporter activity did not correspond perfectly to the expression of Zic4 transcripts, with many Zic4+ cells being GFP negative (Fig. 1E,F). The most likely explanation for this was that insufficient time had elapsed following the onset of Zic4 expression for the production of detectable levels of GFP. This delay would have been for the production of Cre recombinase from the Zic4Cre transgene, the consequent activation of the reporter gene and the production of sufficient GFP.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/−;RCE+/− mouse brain coronal sections at E11.5 and E12.5. A, G, Schematics of E11.5 and E12.5 mouse brain demarcating major subdivisions and sectioning planes. B1–F, H1–J3, Zic4 fluorescent in situ hybridization (monochrome in B1, C1, D1, H1, I1, J1 or red in B3, C3, D3, E, F, H3, I3, J3) and immunohistochemistry for GFP reporter of Zic4Cre activity (monochrome in B2, C2, D2, H2, I2, J2 or green in B3, C3, D3, E, F, H3, I3, J3) with DAPI counterstaining (blue). Box in D3 is shown in E; box in E is shown in F. Scale bars: 250 µm (B1–D3, H1–J3), 125 µm (E), 25 µm (F). Cx, cortex; cp, choroid plexus; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence; th, thalamus; pth, prethalamus; emt, eminentia thalami; epi, epithalamus.

At E12.5, Zic4 transcripts were present more widely, from epithalamus through thalamus and prethalamus to eminentia thalami (Fig. 1H1–J1). Expression levels were still highest in the prethalamus, as at E11.5, but were also strong in the epithalamus. In the thalamus, expression levels were highest in more anterior sections. GFP expression showed very similar patterns (Fig. 1H2–J2).

These E12.5 patterns of Zic4 and GFP expression were largely maintained as the tissues grew in size over subsequent days up to birth (Figs. 2, 3). As thalamic nuclei formed during this period, Zic4/GFP+ cells became concentrated in the vLGN, around the border between the thalamus and prethalamus, in anterior thalamic regions and in the epithalamus. By birth, the densest concentration of GFP+ Zic4-lineage cells was in vLGN and the medial habenula of the epithalamus (Fig. 3H,I). Their densities were intermediate in other lateral thalamic nuclei such as the dLGN and in the zona incerta (ZI) of the prethalamus. They were low in midline thalamic nuclei such as nucleus reuniens and the rhomboid nucleus, and almost absent from VP thalamic nuclei such as the ventral posterolateral nucleus (VPL) and ventral posteromedial nucleus (VPM; Fig. 3H,I).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/−;RCE+/− mouse brain coronal sections at E13.5, E14.5, and E15.5. A, E, I, Schematics of E13.5, E14.5, and E15.5 mouse brain demarcating major subdivisions and sectioning planes. B1–D3, F1–H3, J1–L3, Zic4 fluorescent in situ hybridization (monochrome in B1, C1, D1, F1, G1, H1, J1, K1, L1 or red in B3, C3, D3, F3, G3, H3, J3, K3, L3) and immunohistochemistry for GFP reporter of Zic4Cre activity (monochrome in B2, C2, D2, F2, G2, H2, J2, K2, L2 or green in B3, C3, D3, F3, G3, H3, J3, K3, L3) with DAPI counterstaining (blue). Scale bars: 250 µm. vLGN, ventral lateral geniculate nucleus; th, thalamus; pth, prethalamus.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Expression of Zic4 and activity of Zic4Cre in Zic4Cre+/−;RCE+/− mouse brain coronal sections at E16.5, E18.5, and P0. A, E, H, Schematics of E16.5, E18.5, and P0 mouse brain demarcating major subdivisions and nuclei and sectioning planes. B1–D3, F1–G3, Zic4 fluorescent in situ hybridization (monochrome in B1, C1, D1, F1, G1 or red in B3, C3, D3, F3, G3) and immunohistochemistry for GFP reporter of Zic4Cre activity (monochrome in B2, C2, D2, F2, G2 or green in B3, C3, D3, F3, G3, I) with DAPI counterstaining (blue). Scale bars: 250 µm (B1–G3), 500 µm (I). Cx, cortex; dLGN, dorsal lateral geniculate nucleus; Hippo, hippocampus; LD, lateral dorsal nucleus; LH, lateral habenula; LP, lateral posterior nucleus; MD, medial dorsal nucleus; MH, medial habenula; PO, posterior nucleus; pth, prethalamus; PV, paraventricular nucleus; RE, nucleus reunions; RH, rhomboid nucleus; SPF, subparafascicular thalamic nucleus; th, thalamus; VAL, ventral anterolateral nucleus; vLGN, ventral lateral geniculate nucleus; VM, ventromedial nucleus; VPL, ventral posterolateral nucleus; VPM = ventral posteromedial nucleus; vTel, ventral telencephalon; ZI, zona incerta. H, Adapted from Allen Brain Atlas (http://developingmouse.brain-map.org/).

These findings indicate that Zic4-lineage diencephalic progenitors contribute their daughter cells mainly to the thalamic nuclei that are close to the boundary between thalamus and prethalamus, particularly to the vLGN but also to others such as the dLGN.

Overlap between Zic4-lineage and Pax6-expressing cells

The normal expression pattern of Pax6 is shown at E12.5, E13.5, E14.5, and E16.5 in Figures 4A1–F1, 5A1–G1, 6A1–G1, 7A1–F1. Pax6 is expressed at some level in almost all progenitors throughout the epithalamus, thalamus, prethalamus, and eminentia thalami, the exceptions being located in the ZLI, a small strip of tissue between the thalamus and prethalamus (Fig. 4E1). In thalamus, it is distributed in a gradient with the lowest levels close to the border with the prethalamus (Figs. 4A1–E1, 5A1–E1). Since it is not expressed by postmitotic thalamic neurons, it almost completely disappears once the progenitor population is exhausted by E16.5 (Fig. 7A1–F1).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Pax6 expression in control and Pax6 mutant embryos at E12.5. Immunohistochemistry for Pax6 on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 1. Boxed areas in B1–B3 are enlarged in F1–F3. ZLI, zona limitans intrathalamica; epi, epithalamus; th, thalamus; pth, prethalamus; emt, eminentia thalami; h, hypothalamus. Scale bars: 500 µm (A1–E3), 50 µm (F1–F3).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Pax6 expression in control and Pax6 mutant embryos at E13.5. Immunohistochemistry for Pax6 on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 2. Boxed areas in A1–B3 are enlarged in F1–G3. vLGN, ventral lateral geniculate nucleus; epi, epithalamus; th, thalamus; pth, prethalamus; emt, eminentia thalami; h, hypothalamus. Scale bars: 500 µm (A1–E3), 50 µm (F1–F3).

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Pax6 expression in control and Pax6 mutant embryos at E14.5. (A1–G3) Immunohistochemistry for Pax6 on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 2, arranged from anterior (A1–A3) to posterior (G1–G3). ZI, zona incerta; vLGN, ventral lateral geniculate nucleus; th, thalamus; pth, prethalamus; emt, eminentia thalami. Scale bar: 500 µm.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Pax6 expression in control and Pax6 mutant embryos at E16.5. (A1–F3)Immunohistochemistry for Pax6 on a set of sections cut through the diencephalon in similar planes of section to those shown in Figure 3, arranged from anterior (A1–A3) to posterior (F1–F3). ZI, zona incerta; vLGN, ventral lateral geniculate nucleus; th, thalamus; pth, prethalamus. Scale bar: 500 µm.

In the prethalamus, Pax6 is strongly expressed by progenitors and is retained by many postmitotic cells as they migrate radially into the diencephalic mantle zone (Figs. 4A1–E1, 5A1–E1, 6A1–G1). These cells form a Pax6-positive strip running across the prethalamus. At early stages, some of them migrate as far as the outer edge of the neuroepithelium to a region where the vLGN will form (Fig. 5B1–E1,G1). By E14.5, when the development of discrete diencephalic nuclei is underway, most Pax6-expressing cells are located in the ZI of the prethalamus (Fig. 6A1–G1). At E14.5 and E16.5, we observed small numbers of Pax6-expressing cells in the vicinity of the vLGN, mostly around rather than within it (Figs. 6E1–G1, 7D1–F1).

As expected, given that Pax6 is expressed by almost all thalamic and prethalamic progenitors, double-label experiments showed that Zic4-lineage thalamic and prethalamic progenitor cells express Pax6 as early as E11.5 (Fig. 8). Many Zic4-lineage postmitotic cells in the prethalamus retained Pax6 (e.g., yellow asterisks in Fig. 8C); others did not (e.g., green asterisks in Fig. 8C). We went on to use the Zic4Cre allele to test the effects of mutating one or both copies of the Pax6 gene in Zic4-lineage cells.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Diencephalic Zic4-lineage cells express Pax6. Double-immunohistochemistry for GFP (Zic4-lineage cells) and Pax6 at E11.5. Area outlined in B is enlarged in C. Asterisks in C: yellow, examples of double-labeled cells; green, examples of cells labeled only with GFP; red, examples of cells labeled only for Pax6. Scale bars: 250 µm (A), 50 µm (B), 10 µm (C).

Zic4Cre-induced deletion of Pax6

We studied Pax6 expression in Zic4Cre;Pax6fl/+ and Zic4Cre;Pax6fl/fl embryos at E12.5, E13.5, E14.5, and E16.5. For each genotype at each age, we examined three non-littermate embryos and the results were indistinguishable. In Zic4Cre;Pax6fl/fl homozygous mutant embryos (Figs. 4A3–F3, 5A3–G3, 6A3–G3, 7A3–F3), the numbers of cells immunostained for Pax6 declined rapidly in the thalamus from E12.5 onwards, particularly in its anterior parts where many cells are Zic4-lineage. By E14.5, there were almost no Pax6-expressing progenitors in the thalamus in Zic4Cre;Pax6fl/fl embryos whereas normally a small population remained. The numbers of Pax6-expressing cells in the prethalamus of Zic4Cre;Pax6fl/fl embryos were greatly reduced at all ages. There were no consistent defects in the overall shapes and sizes of diencephalic structures.

In Zic4Cre;Pax6fl/+ heterozygotes, we detected no defects of Pax6 expression at E12.5–E14.5 (Figs. 4A2–F2, 5A2–G2, 6A2–G2). By E16.5, however, the numbers of Pax6-expressing cells had declined throughout the prethalamus and the intensity of the immunostaining of many Pax6-expressing cells was lower than normal (Fig. 7A2–F2). The pattern of Pax6 expression in Zic4Cre;Pax6fl/+ embryos now appeared intermediate between controls and Zic4Cre;Pax6fl/fl embryos. There were no detectable defects in the positions of the Pax6-expressing cells. The overall shapes and sizes of diencephalic structures appeared normal. These findings indicate that mutation of one copy of Pax6 in Zic4-lineage cells causes them to lower their Pax6 levels between E14.5 and E16.5, i.e., once they are postmitotic neurons, with levels in some falling below the threshold for detection.

Cells of the vLGN, dLGN, and the VP nuclei are generated before E14.5

We selected three thalamic nuclei to search for defects resulting from mutation of Pax6 in Zic4-lineage cells: vLGN, which contains a large proportion of Zic4-lineage cells at birth; dLGN, which contains an intermediate proportion of Zic4-lineage cells at birth; VP nuclei (VPM and VPL), which contain low numbers of Zic4-lineage cells at birth.

As a first step toward testing whether Pax6 mutation in Zic4-lineage cells affects the progenitors that give rise to these nuclei, we checked the ages at which vLGN, dLGN, and VP cells are generated. We injected BrdU into control embryos at E10.5–E13.5 and studied BrdU labeling at birth (P0). To help identify the nuclei we used several markers: COUP-TFI, COUP-TFII, LIM1/2, and Nkx2.2 (Fig. 9A–D). COUP-TFI is expressed across most of the thalamic nuclei including the vLGN, dLGN, and VP. The expression level of COUP-TFI in the vLGN is lower than the surrounding nuclei such as the dLGN and VP and, within the vLGN, is highest in the middle of the nucleus (Fig. 9A). COUP-TFII is expressed strongly in the prethalamus and helped determine the anterior boundaries of the vLGN and VP (Fig. 9C). LIM1/2 and Nkx2.2 are strongly expressed in the vLGN but not in the dLGN or VP (Fig. 9B,D).

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

Birthdates of cells in the vLGN, dLGN, and VP. A–D, Immunohistochemistry at P0 with markers designed to help delineate borders of the thalamic nuclei analyzed here. Scale bar: 100 µm. E, F, Example of BrdU and GFP immunohistochemistry in vLGN. Scale bars: 100 µm (E), 10 µm (F). G, Proportions of all cells in each nucleus that were BrdU+ after injection with BrdU at E10.5–E13.5. H, Proportions of GFP-expressing cells in each nucleus that were BrdU+ after injection with BrdU at E10.5–E13.5. Data points are from individual animals. Mean ± SEM are shown in each case. One-way ANOVA returned significant effects of age in all cases: (G) vLGN F(3,12) = 7.729, p = 0.0039; dLGN F(3,12) = 13.56, p = 0.0004; VP F(3,12) = 20.76, p < 0.0001; (H) vLGN F(3,12) = 8.282, p = 0.0030; dLGN F(3,12) = 15.41, p = 0.0002; VP F(3,12) = 23.26, p < 0.0001. Holm–Sidak’s multiple comparisons tests were performed following one-way ANOVA: *p < 0.05; **p < 0.01; ***p < 0.001.

We counted BrdU-labeled cells as a proportion of all cells and as a proportion of Zic4-lineage (GFP+) cells in each nucleus (Fig. 9E,F). We found that the vast majority of cells in vLGN, dLGN, and VP are generated after E10.5 and before E13.5 (Fig. 9G,H).

Effects of Pax6 mutation in Zic4-lineage cells on cell production

We next used immunostaining for Ki67 (a marker of proliferating cells), Tuj1 (a marker of newly differentiating neurons) and phosphohistone H3 (pHH3; a marker of cells in M-phase of the cell cycle) together with short-term BrdU labeling to assess the activity of progenitors in regions that generate vLGN, dLGN, and VP at E11.5 and E12.5 (Fig. 10). We made measurements in three regions: pTH-C, which gives rise to thalamic nuclei including dLGN and VP; pTH-R, which contributes to nuclei including vLGN; and prethalamus (Fig. 10A). We sampled from four sections through each prethalamus and five through each pTH-C and pTH-R, equally spaced from anterior to posterior, from four embryos of each age and genotype.

Figure 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 10.

Effects of Pax6 mutation in Zic4-lineage cells on early diencephalic progenitor proliferation. A, Triple immunostaining for Tuj1, Ki67, and GFP. Three regions of interest were selected for analysis, one midway through pTH-C, one in pTH-R and one in prethalamus (pth). Scale bars: 50 µm. B, Average growth fractions (±SEM) in five equally spaced sections through pTH-C and pTH-R and four through prethalamus at E11.5 and E12.5; color coding for genotypes as in E. Two-way ANOVA detected significant effects of genotype only in pTH-C (F(2,30) = 9.109, p = 0.0008) and pTH-R (F(2,30) = 11.97, p = 0.0002) at E12.5 (n = 3 embryos of each genotype), with Pax6fl/fl embryos showing lower growth fractions at all levels (post hoc Tukey’s multiple comparisons test, p < 0.01 at all positions). C, Average growth fraction for GFP+ cells only. There were no significant effects of genotype. D, An example of triple immunostaining for pHH3, BrdU, and GFP in one region of interest. E, Mean (±SEM) counts of the total numbers of pHH3+ cells in all sampling regions from each domain for each genotype. There were no significant effects of genotype. F, Average proliferation rates (±SEM) in five equally spaced sections through pTH-C and pTH-R and four through prethalamus at E11.5 and E12.5; color coding for genotypes as in E. Two-way ANOVA showed a significant effect of genotype in pTH-R at E11.5 (F(2,30) = 4.206, p = 0.0245), with lower values in Pax6fl/+ embryos than in the other two genotypes. G, Average proliferation rates for GFP+ cells only. There were no significant effects of genotype.

We first made measurements on all cells in the three regions, i.e., including both GFP+ and GFP- cells. When we examined the percentages of all cells that were proliferative based on their expression of Ki67, referred to as the growth fraction, we found small but significant decreases in Pax6fl/fl pTH-C and pTH-R (Fig. 10B). When we measured this same parameter specifically in GFP+ (Zic4-lineage) cells, we found no significant effects of genotype (Fig. 10C). There were no intergenotypic differences in the numbers of pHH3+ cells in any region at either age (Fig. 10D,E). We then measured the proportions of proliferating cells (Ki67+) that were in S-phase (BrdU+), which is an indication of their rate of proliferation (i.e., the longer the cell cycle, the lower the proportion of cells in S-Phase within the defined time window). When we examined all cells, we identified a small but significant decrease at E11.5 in Pax6fl/fl pTH-R (Fig. 10F). When we examined GFP+ cells alone, we found no significant effects of genotype (Fig. 10G).

These findings indicate that the loss of both copies of Pax6 in Zic4-lineage has a minor effect on proliferation, causing decreases in pTH-C and/or pTH-R at some ages, which was only detectable in the overall population of progenitors and not specifically the Zic4-lineage progenitors themselves.

Pax6 mutation in Zic4-lineage cells increases their contribution to vLGN and dLGN

We then analyzed the effects of Pax6 mutation in Zic4-lineage cells on the numbers of these cells that contribute to vLGN, dLGN, and VP at P0 (Fig. 11). We first estimated the total numbers of cells in each of these nuclei by sampling the densities of all counterstained cells in each nucleus and multiplying by its volume. Volumes were estimated using the ImageJ Volumest plugin on a series of 10 coronal sections with a regular interval of 60 µm from each brain sample. We found no significant intergenotypic differences, indicating that Pax6 mutation in Zic4-lineage cells did not alter overall numbers of cells contributing to these nuclei (Fig. 11D–F).

Figure 11.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 11.

Pax6 mutation in Zic4-lineage cells increases their contribution to vLGN and dLGN. A–C, Sections from rostral to caudal through the diencephalon of P0 Zic4Cre;Pax6+/+, Zic4Cre;Pax6fl/+, and Zic4Cre;Pax6fl/fl embryos. Scale bar: 750 µm. D–F, Total numbers of cells in vLGN, dLGN, and VP in four P0 pups of each genotype; individual values, mean ± SEM are shown. There were no significant effects of genotype. G–I, Proportions of GFP+ (i.e., Zic4-lineage) cells in sections equally spaced through the vLGN, dLGN, and VP of P0 Zic4Cre;Pax6+/+, Zic4Cre;Pax6fl/+, and Zic4Cre;Pax6fl/fl pups. In vLGN and dLGN, two-way ANOVA showed significant effects of genotype: vLGN, F(2,90) = 23.98, p < 0.0001; dLGN, F(2,60) = 140.4, p < 0.0001. In VP, there were no significant effects. Data are plotted using mean and SEM using at least three pups of each genotype (n = 4 for vLGN and n = 3 for dLGN and VP).

We measured the proportions of cells in each of these nuclei that were Zic4-lineage (i.e., GFP+). We found that these proportions were significantly increased in the dLGN of Pax6fl/fl embryos (Fig. 11A,C,H). They were increased even more in the dLGN of Pax6fl/+ embryos, with more than twice the normal proportions of Zic4-lineage cells contributing (Fig. 11A,B,H). Proportions were also increased in the vLGN of Pax6fl/+ embryos (Fig. 11A,B,G). The increases in the dLGN were seen in anterior sections in Pax6fl/fl embryos and throughout all sections in Pax6fl/+ embryos (Fig. 11H). The increases in the vLGN in Pax6fl/+ embryos were greater in more posterior sections (Fig. 11G). There were no intergenotypic differences in VP (Fig. 11I).

These findings indicate that the dLGN increases its content of Zic4-lineage cells at the expense of Zic4-non-lineage cells if the Zic4-lineage cells are Pax6fl/fl or Pax6fl/+. The vLGN increases its content of Zic4-lineage cells at the expense of Zic4-non-lineage cells if the Zic4-lineage cells are Pax6fl/+.

Discussion

We have found that Zic4-lineage cells normally contribute ∼50% of vLGN cells, ∼25% of dLGN cells, and ∼10% of VP cells at birth. Heterozygosity for a loss-of-function mutation of Pax6 in Zic4-lineage cells greatly increased the contribution that these cells make to the vLGN and dLGN, but not the VP. Homozygosity for the same mutation had a smaller effect on the contribution of Zic4-lineage cells to the dLGN and no effect on contribution to vLGN and VP.

These changes are most likely explained by a redistribution of mutant Zic4-lineage cells into the dLGN and vLGN. Our findings argue against an alternative explanation involving overproduction of mutant Zic4-lineage cells. When we tested whether Pax6 mutation, either heterozygous or homozygous, had an effect on the early proliferation of specifically the Zic4-lineage progenitors, we found none. We did find slight decreases in proliferation in some regions at some ages when we considered the overall populations of progenitors, both Zic4-lineage and Zic4-non-lineage. These finding suggest that some change in the Zic4-lineage cells, perhaps involving altered signaling, had a cell non-autonomous effect on the Zic4-non-lineage cells. It does not, however, provide a straightforward explanation for the increased numbers of mutant Zic4-lineage cells in the dLGN and vLGN. Another reason that redistribution of postmitotic cells is a more likely mechanism than altered production is that the effects of heterozygosity for Pax6 mutation on Pax6 protein levels only became obvious in postmitotic cells and not in progenitors.

Figure 12 summarizes our model. The ZLI and the two progenitor domains posterior to it, pTH-R and pTH-C (Fig. 12C,E), express substantially different sets of regulatory genes. For example, the ZLI expresses Shh, pTH-R expresses transcription factors such as Nkx2.2 and Asc1, and pTH-C expresses Neurog1 and Neurog2. Several previous fate mapping studies have used genetic tools to exploit these early gene expression patterns to link specific sets of progenitors with mature diencephalic nuclei (Vue et al., 2007, 2009; Delaunay et al., 2009; Jeong et al., 2011; Suzuki-Hirano et al., 2011). These studies showed that the ZLI and adjacent pTH-R contribute to the vLGN, whereas more caudal progenitors in pTH-C contribute progressively to more caudal thalamic nuclei. In other words, the relative positions of thalamic progenitors are well preserved in the spatial arrangement of the nuclei they generate. Pax6 is expressed in a gradient by thalamic progenitors, with its lowest levels in pTH-R and no expression in the ZLI (Fig. 12C,E). This means that the Zic4-lineage cells that distribute to the vLGN and dLGN are derived mainly from progenitors that express little or no Pax6. If homozygous or heterozygous mutation causes Zic4-lineage cells to lose or lower their levels of Pax6, then these cells or their daughters preferentially distribute to nuclei that are generated from progenitors that express little or no Pax6. This suggests that the positional information encoded by the levels of Pax6 in diencephalic progenitors is an important determinant of the eventual locations of their daughter cells.

Figure 12.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 12.

Model. A, B, Sections through the embryonic thalamus (th) and prethalamus (pth) showing the locations of the ZLI (red) and pTH-R (dark blue). C, D, Normally, Zic4-lineage cells from progenitors in the ZLI and pTH-R, which express little or no Pax6, contribute to the vLGN. Zic4-lineage cells from progenitors in rostral pTH-C (i.e., close to pTH-R), whose levels of Pax6 are relatively low, contribute to dLGN. Zic4-lineage cells in prethalamus (pth), which express Pax6 at high levels in both progenitors and postmitotic neurons, contribute to prethalamic regions including the ZI. E, F, Mutant Zic4-lineage cells concentrate in the vLGN and/or dLGN, which are derived from thalamic progenitors that normally express little or no Pax6.

A likely mechanism by which Pax6 levels effect the distribution of diencephalic neurons is through its regulation of cell adhesion molecules that cause cells to sort on the basis of their intercellular interactions. It has long been appreciated in many different systems that cells aggregate if they have similar levels of cadherins (Foty and Steinberg, 2005; Halbleib and Nelson, 2006). In the postnatal mouse brain, different thalamic nuclei express distinct combinations of cadherins: for example, the vLGN and dLGN express Cadherin 5, 8, and 11, whereas VP expresses mainly Cadherin 6 and 11 (Suzuki et al., 1997; Hirano and Takeichi, 2012). Both in vivo and in vitro studies have shown that Pax6 can regulate molecules such as R-cadherin, L1 cell adhesion molecule and N-CAM (Chalepakis et al., 1994; Edelman and Jones, 1995; Holst et al., 1997; Stoykova et al., 1997; Meech et al., 1999; Andrews and Mastick, 2003; Tyas et al., 2003).

Why Zic4-lineage cells heterozygous for a mutation of Pax6 cause a greater redistribution of Zic4-lineage cells affecting both dLGN and vLGN is not clear. One possibility stems from our observation that heterozygosity has a relatively late effect on Pax6 levels in postmitotic neurons, which contribute mainly to the prethalamus. A reduction of Pax6 levels in migrating prethalamic neurons might allow significant numbers of these cells to migrate in an abnormal direction across the boundary from prethalamus into the vLGN and dLGN. The numbers that do this might be greater than the numbers that sort incorrectly following loss of Pax6 from progenitors, as occurs in homozygous deletion. Progenitors might possess a degree of plasticity that allows them to compensate to some degree if they lose Pax6, thereby minimizing the consequences for later sorting of their postmitotic cells.

Whatever the cause of the strong effect of Pax6 heterozygosity, this finding is particularly relevant to human disease caused by PAX6 haploinsufficiency. In humans, heterozygous loss-of-function mutations affecting PAX6 cause a disorder with an incidence of ∼1/50,000 live births. Patients show a range of neurologic and psychiatric symptoms including impaired auditory processing, verbal function and social cognition, autism and mental retardation and altered functional connectivity in intrinsic neural networks (Sisodiya et al., 2001; Free et al., 2003; Mitchell et al., 2003; Ellison-Wright et al., 2004; Thompson et al., 2004; Bamiou et al., 2007; Umeda et al., 2010; Pierce et al., 2014). These functional abnormalities are associated with structural defects of the cerebral cortex and its axonal tracts (Sisodiya et al., 2001). Mice with heterozygous loss-of-function mutations of Pax6 have rarely been used to explore possible pathologies underlying the neurologic and psychiatric symptoms that patients experience. Although one study suggested a slight delay in the onset of corticogenesis in Pax6± embryos (Schmahl et al., 1993), other work found no abnormalities of cortical development in these mice (Mi et al., 2013). Almost nothing is reported on the effects of Pax6± heterozygosity on development of the diencephalon. Given that the dLGN is the relay nucleus for projections to the visual cortex, the findings of this study suggest that defects of the thalamus and geniculocortical pathway might be found in patients.

Acknowledgments

Acknowledgements: We thank the staff at the University of Edinburgh for invaluable help with mouse maintenance; Thomas Theil and Nicoletta Kessaris for the Zic4Cre mice; Nicoletta Kessaris for the Zic4 plasmids; Dr. Martine Manuel for advising and colony managing; Anisha Kubasik-Thayil for helping with confocal microscopy; Vivian Alison and Louis Dunn for helping with histology; and Mike Molinek for supervising the laboratory work.

Footnotes

  • The authors declare no competing financial interests.

  • This work was supported by the Medical Research Council Grant MR/N012291/1 (to D.J.P.) and by an Edinburgh University Global Research Scholarship and Principal’s Career Development Scholarship (Z.L.).

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Andrews GL, Mastick GS (2003) R-cadherin is a Pax6-regulated, growth-promoting cue for pioneer axons. J Neurosci 23:9873–9880. pmid:14586016
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Aruga J, Nagai T, Tokuyama T, Hayashizaki Y, Okazaki Y, Chapman VM, Mikoshiba K (1996a) The mouse zic gene family. Homologues of the Drosophila pair-rule gene odd-paired. J Biol Chem 271:1043–1047. pmid:8557628
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Aruga J, Yozu A, Hayashizaki Y, Okazaki Y, Chapman VM, Mikoshiba K (1996b) Identification and characterization of Zic4, a new member of the mouse Zic gene family. Gene 172:291–294. pmid:8682319
    OpenUrlCrossRefPubMed
  4. ↵
    Bamiou DE, Free SL, Sisodiya SM, Chong WK, Musiek F, Williamson KA, van Heyningen V, Moore AT, Gadian D, Luxon LM (2007) Auditory interhemispheric transfer deficits, hearing difficulties, and brain magnetic resonance imaging abnormalities in children with congenital aniridia due to PAX6 mutations. Arch Pediatr Adolesc Med 161:463–469. doi:10.1001/archpedi.161.5.463 pmid:17485622
    OpenUrlCrossRefPubMed
  5. ↵
    Caballero IM, Manuel MN, Molinek M, Quintana-Urzainqui I, Mi D, Shimogori T, Price DJ (2014) Cell-autonomous repression of Shh by transcription factor Pax6 regulates diencephalic patterning by controlling the central diencephalic organizer. Cell Rep 8:1405–1418. doi:10.1016/j.celrep.2014.07.051 pmid:25176648
    OpenUrlCrossRefPubMed
  6. ↵
    Chalepakis G, Wijnholds J, Giese P, Schachner M, Gruss P (1994) Characterization of Pax-6 and Hoxa-1 binding to the promoter region of the neural cell adhesion molecule L1. DNA Cell Biol 13:891–900. doi:10.1089/dna.1994.13.891 pmid:7917011
    OpenUrlCrossRefPubMed
  7. ↵
    Delaunay D, Heydon K, Miguez A, Schwab M, Nave KA, Thomas JL, Spassky N, Martinez S, Zalc B (2009) Genetic tracing of subpopulation neurons in the prethalamus of mice (Mus musculus). J Comp Neurol 512:74–83. doi:10.1002/cne.21904 pmid:18973275
    OpenUrlCrossRefPubMed
  8. ↵
    Edelman GM, Jones FS (1995) Developmental control of N-CAM expression by Hox and Pax gene products. Philos Trans R Soc Lond B Biol Sci 349:305–312. doi:10.1098/rstb.1995.0118 pmid:8577842
    OpenUrlCrossRefPubMed
  9. ↵
    Ellison-Wright Z, Heyman I, Frampton I, Rubia K, Chitnis X, Ellison-Wright I, Williams SC, Suckling J, Simmons A, Bullmore E (2004) Heterozygous PAX6 mutation, adult brain structure and fronto-striato-thalamic function in a human family. Eur J Neurosci 19:1505–1512. doi:10.1111/j.1460-9568.2004.03236.x
    OpenUrlCrossRefPubMed
  10. ↵
    Ericson J, Rashbass P, Schedl A, Brenner-Morton S, Kawakami A, van Heyningen V, Jessell TM, Briscoe J (1997) Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell 90:169–180. pmid:9230312
    OpenUrlCrossRefPubMed
  11. ↵
    Foty RA, Steinberg MS (2005) The differential adhesion hypothesis: a direct evaluation. Dev Biol 278:255–263. doi:10.1016/j.ydbio.2004.11.012 pmid:15649477
    OpenUrlCrossRefPubMed
  12. ↵
    Free SL, Mitchell TN, Williamson KA, Churchill AJ, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM (2003) Quantitative MR image analysis in subjects with defects in the PAX6 gene. Neuroimage 20:2281–2290. pmid:14683729
    OpenUrlCrossRefPubMed
  13. ↵
    Gaston-Massuet C, Henderson DJ, Greene ND, Copp AJ (2005) Zic4, a zinc-finger transcription factor, is expressed in the developing mouse nervous system. Dev Dyn 233:1110–1115. doi:10.1002/dvdy.20417 pmid:15895369
    OpenUrlCrossRefPubMed
  14. ↵
    Halbleib JM, Nelson WJ (2006) Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev 20:3199–3214. doi:10.1101/gad.1486806 pmid:17158740
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Hirano S, Takeichi M (2012) Cadherins in brain morphogenesis and wiring. Physiol Rev 92:597–634. doi:10.1152/physrev.00014.2011 pmid:22535893
    OpenUrlCrossRefPubMed
  16. ↵
    Holst BD, Wang Y, Jones FS, Edelman GM (1997) A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord. Proc Natl Acad Sci USA 94:1465–1470. pmid:9037076
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Horng S, Kreiman G, Ellsworth C, Page D, Blank M, Millen K, Sur M (2009) Differential gene expression in the developing lateral geniculate nucleus and medial geniculate nucleus reveals novel roles for Zic4 and Foxp2 in visual and auditory pathway development. J Neurosci 29:13672–13683. doi:10.1523/JNEUROSCI.2127-09.2009 pmid:19864579
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Jeong Y, Dolson DK, Waclaw RR, Matise MP, Sussel L, Campbell K, Kaestner KH, Epstein DJ (2011) Spatial and temporal requirements for sonic hedgehog in the regulation of thalamic interneuron identity. Development 138:531–541. doi:10.1242/dev.058917 pmid:21205797
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Jones E (2007) The thalamus. Cambridge, MA: Cambridge University Press.
  20. ↵
    Lamprecht MR, Sabatini DM, Carpenter AE (2007) CellProfiler: free, versatile software for automated biological image analysis. Biotechniques 42:71–75. doi:10.2144/000112257 pmid:17269487
    OpenUrlCrossRefPubMed
  21. ↵
    Lim Y, Golden J (2007) Patterning the developing diencephalon. Brain Res Rev 53:17–26. doi:10.1016/j.brainresrev.2006.06.004 pmid:16876871
    OpenUrlCrossRefPubMed
  22. ↵
    Macdonald R, Barth KA, Xu Q, Holder N, Mikkola I, Wilson SW (1995) Midline signalling is required for Pax gene regulation and patterning of the eyes. Development 121:3267–3278. pmid:7588061
    OpenUrlAbstract
  23. ↵
    Martinez-Ferre A, Martinez S (2012) Molecular regionalization of the diencephalon. Front Neurosci 6:73. doi:10.3389/fnins.2012.00073 pmid:22654731
    OpenUrlCrossRefPubMed
  24. ↵
    Martynoga B, Morrison H, Price DJ, Mason JO (2005) Foxg1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Dev Biol 283:113–127. doi:10.1016/j.ydbio.2005.04.005 pmid:15893304
    OpenUrlCrossRefPubMed
  25. ↵
    Meech R, Kallunki P, Edelman GM, Jones FS (1999) A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins. Proc Natl Acad Sci USA 96:2420–2425. pmid:10051657
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Merzin M (2008) Applying stereological method in radiology. Volume measurement. Bachelor’s thesis. University of Tartu.
  27. ↵
    Mi D, Carr CB, Georgala PA, Huang YT, Manuel MN, Jeanes E, Niisato E, Sansom SN, Livesey FJ, Theil T, Hasenpusch-Theil K, Simpson TI, Mason JO, Price DJ (2013) Pax6 exerts regional control of cortical progenitor proliferation via direct repression of Cdk6 and hypophosphorylation of pRb. Neuron 78:269–284. doi:10.1016/j.neuron.2013.02.012 pmid:23622063
    OpenUrlCrossRefPubMed
  28. ↵
    Mitchell TN, Free SL, Williamson KA, Stevens JM, Churchill AJ, Hanson IM, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM (2003) Polymicrogyria and absence of pineal gland due to PAX6 mutation. Ann Neurol 53:658–663. doi:10.1002/ana.10576 pmid:12731001
    OpenUrlCrossRefPubMed
  29. ↵
    Miyoshi G, Hjerling-Leffler J, Karayannis T, Sousa VH, Butt SJ, Battiste J, Johnson JE, Machold RP, Fishell G (2010) Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons. J Neurosci 30:1582–1594. doi:10.1523/JNEUROSCI.4515-09.2010 pmid:20130169
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Nakagawa Y, Shimogori T (2012) Diversity of thalamic progenitor cells and postmitotic neurons. Eur J Neurosci 35:1554–1562. doi:10.1111/j.1460-9568.2012.08089.x pmid:22607001
    OpenUrlCrossRefPubMed
  31. ↵
    Pierce JE, Krafft CE, Rodrigue AL, Bobilev AM, Lauderdale JD, McDowell JE (2014) Increased functional connectivity in intrinsic neural networks in individuals with aniridia. Front Hum Neurosci 8:1013. doi:10.3389/fnhum.2014.01013 pmid:25566032
    OpenUrlCrossRefPubMed
  32. ↵
    Robertshaw E, Matsumoto K, Lumsden A, Kiecker C (2013) Irx3 and Pax6 establish differential competence for Shh-mediated induction of GABAergic and glutamatergic neurons of the thalamus. Proc Natl Acad Sci USA 110:E3919–E3926. doi:10.1073/pnas.1304311110 pmid:24065827
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Rubin AN, Alfonsi F, Humphreys MP, Choi CK, Rocha SF, Kessaris N (2010) The germinal zones of the basal ganglia but not the septum generate GABAergic interneurons for the cortex. J Neurosci 30:12050–12062. doi:10.1523/JNEUROSCI.6178-09.2010
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Schmahl W, Knoedlseder M, Favor J, Davidson D (1993) Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta Neuropathol 86:126–135. pmid:8213068
    OpenUrlCrossRefPubMed
  35. ↵
    Sherman S, Guillery R (2002) The role of the thalamus in the flow of information to the cortex. Philos Trans R Soc Lond B Biol Sci 357:1695–1708. doi:10.1098/rstb.2002.1161 pmid:12626004
    OpenUrlCrossRefPubMed
  36. ↵
    Sherman S, Guillery R (2006) Exploring the thalamus and its role in cortical function. Cambridge, MA: MIT Press.
  37. ↵
    Sherman S, Guillery R (2011) Distinct functions for direct and transthalamic corticocortical connections. Journal of Neurophysiology 106:1068–1077. doi:10.1152/jn.00429.2011 pmid:21676936
    OpenUrlCrossRefPubMed
  38. ↵
    Simpson TI, Pratt T, Mason JO, Price DJ (2009) Normal ventral telencephalic expression of Pax6 is required for normal development of thalamocortical axons in embryonic mice. Neural Dev 4:19. doi:10.1186/1749-8104-4-19
    OpenUrlCrossRefPubMed
  39. ↵
    Sisodiya SM, Free SL, Williamson KA, Mitchell TN, Willis C, Stevens JM, Kendall BE, Shorvon SD, Hanson IM, Moore AT, van Heyningen V (2001) PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet 28:214–216. doi:10.1038/90042 pmid:11431688
    OpenUrlCrossRefPubMed
  40. ↵
    Stoykova A, Götz M, Gruss P, Price J (1997) Pax6-dependent regulation of adhesive patterning, R-cadherin expression and boundary formation in developing forebrain. Development 124:3765–3777. pmid:9367432
    OpenUrlAbstract
  41. ↵
    Suzuki SC, Inoue T, Kimura Y, Tanaka T, Takeichi M (1997) Neuronal circuits are subdivided by differential expression of type-II classic cadherins in postnatal mouse brains. Mol Cell Neurosci 9:433–447. doi:10.1006/mcne.1997.0626 pmid:9361280
    OpenUrlCrossRefPubMed
  42. ↵
    Suzuki-Hirano A, Ogawa M, Kataoka A, Yoshida AC, Itoh D, Ueno M, Blackshaw S, Shimogori T (2011) Dynamic spatiotemporal gene expression in embryonic mouse thalamus. J Comp Neurol 519:528–543. doi:10.1002/cne.22531
    OpenUrlCrossRefPubMed
  43. ↵
    Thompson PJ, Mitchell TN, Free SL, Williamson KA, Hanson IM, van Heyningen V, Moore AT, Sisodiya SM (2004) Cognitive functioning in humans with mutations of the PAX6 gene. Neurology 62:1216–1218. pmid:15079031
    OpenUrlPubMed
  44. ↵
    Tyas DA, Pearson H, Rashbass P, Price DJ (2003) Pax6 regulates cell adhesion during cortical development. Cereb Cortex 13:612–619. pmid:12764036
    OpenUrlCrossRefPubMed
  45. ↵
    Umeda T, Takashima N, Nakagawa R, Maekawa M, Ikegami S, Yoshikawa T, Kobayashi K, Okanoya K, Inokuchi K, Osumi N (2010) Evaluation of Pax6 mutant rat as a model for autism. PLoS One 5:e15500. doi:10.1371/journal.pone.0015500 pmid:21203536
    OpenUrlCrossRefPubMed
  46. ↵
    Vue TY, Aaker J, Taniguchi A, Kazemzadeh C, Skidmore JM, Martin DM, Martin JF, Treier M, Nakagawa Y (2007) Characterization of progenitor domains in the developing mouse thalamus. J Comp Neurol 505:73–91. doi:10.1002/cne.21467 pmid:17729296
    OpenUrlCrossRefPubMed
  47. ↵
    Vue TY, Bluske K, Alishahi A, Yang LL, Koyano-Nakagawa N, Novitch B, Nakagawa Y (2009) Sonic hedgehog signaling controls thalamic progenitor identity and nuclei specification in mice. J Neurosci 29:4484–4497. doi:10.1523/JNEUROSCI.0656-09.2009 pmid:19357274
    OpenUrlAbstract/FREE Full Text

Synthesis

Reviewing Editor: Alfonso Represa, INSERM

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: NONE. Note: If this manuscript was transferred from JNeurosci and a decision was made to accept the manuscript without peer review, a brief statement to this effect will instead be what is listed below.

Taking into consideration the comments of J Neurosci reviewers and taking into consideration the quality of the work and the interest of the study, I consider the paper suitable for publication in eNeuro

Back to top

In this issue

eneuro: 5 (5)
eNeuro
Vol. 5, Issue 5
September/October 2018
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Zic4-Lineage Cells Increase Their Contribution to Visual Thalamic Nuclei during Murine Embryogenesis If They Are Homozygous or Heterozygous for Loss of Pax6 Function
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Zic4-Lineage Cells Increase Their Contribution to Visual Thalamic Nuclei during Murine Embryogenesis If They Are Homozygous or Heterozygous for Loss of Pax6 Function
Ziwen Li, Thomas Pratt, David J. Price
eNeuro 9 October 2018, 5 (5) ENEURO.0367-18.2018; DOI: 10.1523/ENEURO.0367-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Zic4-Lineage Cells Increase Their Contribution to Visual Thalamic Nuclei during Murine Embryogenesis If They Are Homozygous or Heterozygous for Loss of Pax6 Function
Ziwen Li, Thomas Pratt, David J. Price
eNeuro 9 October 2018, 5 (5) ENEURO.0367-18.2018; DOI: 10.1523/ENEURO.0367-18.2018
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • lateral geniculate nucleus
  • Pax6
  • Prethalamus
  • thalamus
  • Zic4

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Confirmation

  • Hippocampal neuronal activity preceding stimulus predicts later memory success
  • Supramodal representation of the sense of body ownership in the human parieto-premotor and extrastriate cortices
  • Evaluating the Burstlet Theory of Inspiratory Rhythm and Pattern Generation
Show more Confirmation

Development

  • Development of the Functional Connectome Topology in Adolescence: Evidence from Topological Data Analysis
  • Dscam1: Is It a Ubiquitous Code for Dendritic Arborization?
  • Microglia maintain homeostatic conditions in the developing rostral migratory stream
Show more Development

Subjects

  • Development

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.